Investing
Investors are flocking to bonds issued by (almost all) of the Magnificent Seven companies, drawn in by some of the juiciest yields seen on...
Hi, what are you looking for?
iFintechWorld
iFintechWorld
Investing
U.S. natural-gas supplies in storage marked their biggest weekly decline in nearly three years — but that wasn’t enough to rally prices for the...
Investing
Oil futures rose Thursday to settle at their highest prices since late November after government data showed larger-than-anticipated drops in U.S. crude inventories and...
Investing
Oil prices gave up early losses to finish higher on Friday — with production outages in the U.S., strong economic data and concerns about...
Investing
All large cryptocurrencies were down during morning trading on Tuesday, with Uniswap UNIUSD, -6.67% seeing the biggest move, declining 5.12% to $3.93. Polkadot DOTUSD,...
Investing
Bonds issued by troubled drugstore chain Rite Aid Corp. sold off on Monday, after the company filed for bankruptcy, facing billions of dollars of debt...
Investing
The days of the aspirational, marketing-driven corporate sustainability report are dead. In their place, consumers, investors, and regulators now expect companies to have some...
Investing
Ford Motor Co. Executive Chair Bill Ford has jolted markets by saying that Tesla Inc. and other carmakers are “loving” the ongoing United Auto...
Investing
Oil futures ended lower on Monday after a jump at the end of last week, with prices pressured by a report that the U.S....
Investing
In his 1865 book ‘The Coal Question’, economist William Stanley Jevons postulated that the invention of the steam engine, the great productivity leap of...
Investing
By Will Feuer Moderna backed its Covid-19 vaccine sales outlook for the year, saying the guidance already accounts for the uncertainty of U.S. vaccination...
Investing
Key News Asian equities were higher on light volumes as investors kept an eye on the Middle East. Ten state-owned-enterprises (SOEs) announced new or...
Investing
By Will Feuer Shares of Omeros were cut nearly in half after the company said it is discontinuing its late-stage clinical trial evaluating its...
